Literature DB >> 9584969

A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use.

G Di Chiara1.   

Abstract

The effects of drugs and substances of abuse on central dopamine (DA) transmission studied by in vivo monitoring techniques have been examined and compared with those of conventional reinforcers and in particular with food. The similarities and differences in the action of drugs and conventional reinforcers on DA transmission can provide the basis for an hypothesis of the mechanism of drug addiction and compulsive drug use. This hypothesis states that drug addiction is due to excessive control over behaviour exerted by drug-related stimuli as a result of abnormal motivational learning induced by repeated drug exposure. Such abnormal motivational learning would derive from the repetitive non-habituating property of drugs of abuse to activate DA transmission phasically in the nucleus accumbens (NAc) 'shell'. Thus, activation of DA transmission by conventional reinforcers is under strong inhibitory control by previous exposure to the reinforcer (habituation); this, however, is not the case with drug reinforcers. Repetitive, non-adaptive release of DA in the NAc 'shell' by drugs of abuse would result in abnormal strengthening of stimulus-reward (incentive learning) and stimulus-response associations (habit learning) that constitute the basis for craving and compulsive drug use.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9584969     DOI: 10.1177/026988119801200108

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  78 in total

Review 1.  The neuroscience of natural rewards: relevance to addictive drugs.

Authors:  Ann E Kelley; Kent C Berridge
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

2.  NMDA, but not dopamine D(2), receptors in the rat nucleus accumbens areinvolved in guidance of instrumental behavior by stimuli predicting reward magnitude.

Authors:  W Hauber; I Bohn; C Giertler
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 3.  Shared and unique mechanisms underlying binge eating disorder and addictive disorders.

Authors:  Erica M Schulte; Carlos M Grilo; Ashley N Gearhardt
Journal:  Clin Psychol Rev       Date:  2016-02-04

Review 4.  A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue.

Authors:  Andrea Jaquins-Gerstl; Adrian C Michael
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

5.  Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration.

Authors:  Daniele Lecca; Fabio Cacciapaglia; Valentina Valentini; Janne Gronli; Saturnino Spiga; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-01-06       Impact factor: 4.530

Review 6.  Neurobiologic processes in drug reward and addiction.

Authors:  Bryon Adinoff
Journal:  Harv Rev Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.732

7.  Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex.

Authors:  George V Rebec; WenLin Sun
Journal:  J Exp Anal Behav       Date:  2005-11       Impact factor: 2.468

8.  Dissociation of response inhibition and performance monitoring in the stop signal task using event-related fMRI.

Authors:  Andre D Chevrier; Michael D Noseworthy; Russell Schachar
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

9.  Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex.

Authors:  Valentina Bassareo; Maria Antonietta De Luca; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-10-28       Impact factor: 4.530

10.  Reinstatement of cocaine seeking induced by drugs, cues, and stress in adolescent and adult rats.

Authors:  Justin J Anker; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2009-12-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.